用户名  找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊EXPERIMENTAL AND MOLECULAR MEDICINE 2024/2025影响因子:9.527 (EXP MOL MED) (1226-3613). (BIOCHEMISTRY & MOLECULAR BIOL

[复制链接]
查看: 38879|回复: 35
发表于 2025-3-21 18:51:21 | 显示全部楼层 |阅读模式
期刊全称EXPERIMENTAL AND MOLECULAR MEDICINE
期刊简称EXP MOL MED
影响因子20249.527
视频video
ISSN1226-3613
eISSN2092-6413
出版商SPRINGERNATURE
发行地址CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
学科分类1.Science Citation Index Expanded (SCIE)--Biochemistry & Molecular Biology | Medicine, Research & Experimental; 2.Biological Abstracts--Biochemistry & Molecular Biology | Medicine, Research & Experimental; 3.BIOSIS Previews_BIOSIS Citation Index--Biochemistry & Molecular Biology | Medicine, Research & Experimental; 4.Essential Science Indicators--Biology & Biochemistry;
出版语言English
The information of publication is updating

SCIE(SCI)期刊EXPERIMENTAL AND MOLECULAR MEDICINE(20 21 REV HIST)影响因子


SCIE(SCI)期刊EXPERIMENTAL AND MOLECULAR MEDICINE(EXP MOL MED)影响因子@(生物化学与分子生物学)学科排名


SCIE(SCI)期刊EXPERIMENTAL AND MOLECULAR MEDICINE(20 21 REV HIST)总引论文


SCIE(SCI)期刊EXPERIMENTAL AND MOLECULAR MEDICINE(EXP MOL MED)总引论文@(生物化学与分子生物学)学科排名


SCIE(SCI)期刊EXPERIMENTAL AND MOLECULAR MEDICINE(20 21 REV HIST)影响因子


SCIE(SCI)期刊EXPERIMENTAL AND MOLECULAR MEDICINE(EXP MOL MED)总引频次@(生物化学与分子生物学)学科排名


SCIE(SCI)期刊EXPERIMENTAL AND MOLECULAR MEDICINE(20 21 REV HIST)即时影响因子


SCIE(SCI)期刊EXPERIMENTAL AND MOLECULAR MEDICINE(EXP MOL MED)即时影响因子@(生物化学与分子生物学)学科排名


SCIE(SCI)期刊EXPERIMENTAL AND MOLECULAR MEDICINE(20 21 REV HIST)五年累积影响因子


SCIE(SCI)期刊EXPERIMENTAL AND MOLECULAR MEDICINE(EXP MOL MED)五年累积影响因子@(生物化学与分子生物学)学科排名


单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:13:23 | 显示全部楼层
发表于 2025-3-22 04:13:36 | 显示全部楼层
发表于 2025-3-22 07:05:25 | 显示全部楼层
Submitted on: 06 September 2001. Revised on: 03 December 2001. Accepted on: 28 December 2001. ___________________EXPERIMENTAL AND MOLECULAR MEDICINE
发表于 2025-3-22 12:02:44 | 显示全部楼层
Submitted on: 04 May 2020. Revised on: 01 June 2020. Accepted on: 20 July 2020. ___________________EXPERIMENTAL AND MOLECULAR MEDICINE
发表于 2025-3-22 13:16:56 | 显示全部楼层
Submitted on: 09 September 2011. Revised on: 10 November 2011. Accepted on: 06 December 2011. ___________________EXPERIMENTAL AND MOLECULAR MEDICINE
发表于 2025-3-22 19:23:42 | 显示全部楼层
Submitted on: 02 October 2006. Revised on: 26 January 2007. Accepted on: 09 February 2007. ___________________EXPERIMENTAL AND MOLECULAR MEDICINE
发表于 2025-3-22 22:11:02 | 显示全部楼层
Submitted on: 01 December 2023. Revised on: 10 January 2024. Accepted on: 04 March 2024. ___________________EXPERIMENTAL AND MOLECULAR MEDICINE
发表于 2025-3-23 03:39:13 | 显示全部楼层
Submitted on: 05 June 2018. Revised on: 04 August 2018. Accepted on: 28 September 2018. ___________________EXPERIMENTAL AND MOLECULAR MEDICINE
发表于 2025-3-23 06:56:08 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 09:04
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表